ZA937614B - Progestationally active 19,11-bridged 4-estrenes - Google Patents

Progestationally active 19,11-bridged 4-estrenes

Info

Publication number
ZA937614B
ZA937614B ZA937614A ZA937614A ZA937614B ZA 937614 B ZA937614 B ZA 937614B ZA 937614 A ZA937614 A ZA 937614A ZA 937614 A ZA937614 A ZA 937614A ZA 937614 B ZA937614 B ZA 937614B
Authority
ZA
South Africa
Prior art keywords
estrenes
bridged
progestationally active
production
progestationally
Prior art date
Application number
ZA937614A
Other languages
English (en)
Inventor
Weckhard Ottow
Wolfgang Schwede
Wolfgang Halfbrodt
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA937614B publication Critical patent/ZA937614B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Glass Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Eye Examination Apparatus (AREA)
  • Toys (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
ZA937614A 1992-10-13 1993-10-13 Progestationally active 19,11-bridged 4-estrenes ZA937614B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4235220A DE4235220A1 (de) 1992-10-13 1992-10-13 Gestagen wirksame 19,11ß-überbrückte 4-Estrene

Publications (1)

Publication Number Publication Date
ZA937614B true ZA937614B (en) 1994-05-23

Family

ID=6470806

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937614A ZA937614B (en) 1992-10-13 1993-10-13 Progestationally active 19,11-bridged 4-estrenes

Country Status (25)

Country Link
US (2) US5523298A (ja)
EP (1) EP0664811B1 (ja)
JP (1) JP3302366B2 (ja)
KR (1) KR100341066B1 (ja)
CN (1) CN1052238C (ja)
AT (1) ATE156837T1 (ja)
AU (1) AU677019B2 (ja)
BR (1) BR9307232A (ja)
CA (1) CA2146962A1 (ja)
CZ (1) CZ284187B6 (ja)
DE (2) DE4235220A1 (ja)
DK (1) DK0664811T3 (ja)
ES (1) ES2108298T3 (ja)
FI (1) FI951760A (ja)
GR (1) GR3024940T3 (ja)
HU (1) HU223315B1 (ja)
IL (1) IL107232A (ja)
NO (1) NO305440B1 (ja)
NZ (1) NZ256865A (ja)
PL (1) PL179764B1 (ja)
RU (1) RU2157814C2 (ja)
SK (1) SK280991B6 (ja)
TW (1) TW341575B (ja)
WO (1) WO1994009025A1 (ja)
ZA (1) ZA937614B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene
DE4413184A1 (de) * 1994-04-12 1995-10-19 Schering Ag 10,11-C¶3¶-überbrückte Steroide
DE4413185A1 (de) * 1994-04-12 1995-10-19 Schering Ag 11beta,19-überbrückte 13alpha-Alkylsteroide
US5912006A (en) * 1996-08-28 1999-06-15 Eboc, Inc. Compositions and methods for alleviating discomforting menstrual pain
WO2002054064A2 (en) * 2000-12-28 2002-07-11 Schering Ag Method for screening for progesterone receptor isoform-specific ligands
US20040121304A1 (en) * 2001-12-21 2004-06-24 Ulrike Fuhrmann Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligands
GB0219345D0 (en) * 2002-08-20 2002-09-25 Givaudan Sa Improvements in or relating to organic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
DE3708942A1 (de) * 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
US5446178A (en) * 1987-03-18 1995-08-29 Schering Aktiengesellschaft Process for preparing 19,11β-bridged steroids
DE3717169A1 (de) * 1987-05-19 1988-12-01 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
DE3917274A1 (de) * 1989-05-24 1990-11-29 Schering Ag 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4038128A1 (de) * 1990-11-27 1992-06-04 Schering Ag 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene

Also Published As

Publication number Publication date
ATE156837T1 (de) 1997-08-15
RU2157814C2 (ru) 2000-10-20
NO951444D0 (no) 1995-04-12
FI951760A0 (fi) 1995-04-12
HU9501057D0 (en) 1995-06-28
NZ256865A (en) 1996-04-26
HU223315B1 (hu) 2004-05-28
WO1994009025A1 (de) 1994-04-28
KR950703576A (ko) 1995-09-20
IL107232A (en) 1998-06-15
PL179764B1 (pl) 2000-10-31
CN1052238C (zh) 2000-05-10
IL107232A0 (en) 1994-01-25
BR9307232A (pt) 1999-08-24
US5523298A (en) 1996-06-04
GR3024940T3 (en) 1998-01-30
DK0664811T3 (da) 1998-03-30
HUT71523A (en) 1995-12-28
NO305440B1 (no) 1999-05-31
TW341575B (en) 1998-10-01
ES2108298T3 (es) 1997-12-16
SK280991B6 (sk) 2000-10-09
NO951444L (no) 1995-06-13
DE4235220A1 (de) 1994-06-16
DE59307133D1 (de) 1997-09-18
US5703066A (en) 1997-12-30
CZ284187B6 (cs) 1998-09-16
AU677019B2 (en) 1997-04-10
KR100341066B1 (ko) 2002-12-06
JP3302366B2 (ja) 2002-07-15
CA2146962A1 (en) 1994-04-28
FI951760A (fi) 1995-04-12
EP0664811A1 (de) 1995-08-02
JPH08502276A (ja) 1996-03-12
PL308349A1 (en) 1995-07-24
AU5177493A (en) 1994-05-09
RU95109891A (ru) 1997-02-10
CZ91995A3 (en) 1995-09-13
EP0664811B1 (de) 1997-08-13
CN1092428A (zh) 1994-09-21
SK49495A3 (en) 1995-08-09

Similar Documents

Publication Publication Date Title
IL111861A0 (en) N-substituted azabicycloalkane derivatives
GB9514473D0 (en) Chemical compounds
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
ZA948670B (en) New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions
GR3035621T3 (en) New pyrimidone derivatives with antifungal activity
ES8504143A1 (es) Procedimiento para la obtencion de dihidropirimidinas
CA2019404A1 (en) 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
TW261616B (ja)
EP0833819A4 (en) N- (2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3-YL) -3-AMIDE
GR3034602T3 (en) Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides
CA2094806A1 (en) Aminosulfonyl urea acat inhibitors
HU9501057D0 (en) Gestagenically active 19,11-bridged 4-estrenes
EP0842156A4 (en) N- (2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3-YL) -3-AMIDE
MY132057A (en) Quinoxalinones, a process for their preparation and their use
TW252979B (ja)
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
AU693241B2 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
WO1996040760A3 (en) Iodine-containing peptides and their use as x-ray contrast media
ATE80629T1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.
EG21486A (en) Process for the preparation of 2-amino-n-(1,2 diphenyl-1-methylethyl)-acetamide hydrochloride wich are used as medicament
ES2101644A1 (es) Nuevo compuesto derivado del cromeno